Dr. John Mark Bugarin Gubatan, MD

Dr. Gubatan practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Gubatan's NPI, 1215340674, was assigned on June 3, 2014. Dr. Gubatan graduated from Harvard Medical School in 2014. Dr. Gubatan holds California license A154629.

Dr. Gubatan's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Gubatan's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. Dr. Gubatan is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gubatan practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gubatan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gubatan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gubatan's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis and upper GI endoscopy among the conditions Dr. Gubatan treats.

CMS data shows 217 Medicare services from Dr. Gubatan across 8 procedure codes in 2024, for 149 Medicare patients. Medicare paid $26,270 for them.

CMS counts 149 Medicare patients who saw Dr. Gubatan in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gubatan's median patient age at 51, with 50% women.

In 2024, Dr. Gubatan wrote 267 Medicare Part D claims for 67 patients. 72% of them were for generic drugs. CMS names the drug for 120 of them, across 6 drugs with 11 or more claims each, at $14,840 in total drug cost. In 2023, CMS named 160 claims across 9 drugs.

Dr. Gubatan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gubatan as offering telehealth. CMS counts 84 procedures of colonoscopy by Dr. Gubatan, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Gubatan, published from 2010 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Inflammatory Bowel Diseases, Pregnancy Outcome and Premature Birth. Dr. Gubatan's most frequent co-authors are Sarah Elizabeth Streett, MD, David Brian Corry, MD and Farrah Kheradmand, MD.

Dmand AI links Dr. Gubatan to 1 clinical trial. Conditions studied include Dysbiosis and Colitis, Ulcerative.

CMS Open Payments shows 4 general payments to Dr. Gubatan from 3 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $212.

Dmand AI lists 26 awards for Dr. Gubatan, most recently Doris Duke Physician Scientist Fellowship Award in 2023.

Dr. Gubatan graduated from Harvard Medical School in 2014. Dr. Gubatan is a member of ACG, AGA, American Society for Gastrointestinal Endoscopy and European Crohns and Colitis Organisation.

Dr. Gubatan is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.